Q98411271

Summary

Q98411271 is a report^[1].

Key Facts

• Q98411271's instance of is recorded as report^[2].
• Q98411271's part of the series is recorded as reports of the 2009/10 legislative session of the Riksdag^[3].
• Q98411271's language of work or name is recorded as Swedish^[4].
• Q98411271 was published on +2010-05-07T00:00:00Z^[5].
• Q98411271's significant event is recorded as debate^[6].
• Q98411271's main subject is medication^[7].
• Q98411271's work available at URL is recorded as http://data.riksdagen.se/dokument/GX01SoU23^[8].
• Q98411271's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GX01SoU23^[9].
• Q98411271's work available at URL is recorded as http://data.riksdagen.se/fil/930DC2C4-49AD-4B49-8BF2-35DC11FC5926^[10].
• Q98411271's applies to jurisdiction is recorded as Sweden^[11].
• Q98411271's legal citation of this text is recorded as bet. 2009/10:SoU23^[12].
• Q98411271's title is recorded as Ökad kvalitet vid läkemedelsförskrivning^[13].
• Q98411271's has immediate cause is recorded as Q98129470^[14].
• Q98411271's has immediate cause is recorded as Q97824633^[15].
• Q98411271's has immediate cause is recorded as Q97824650^[16].
• Q98411271's has immediate cause is recorded as Q97824703^[17].
• Q98411271's has immediate cause is recorded as Q97824803^[18].
• Q98411271's has immediate cause is recorded as Q97824834^[19].
• Q98411271's has immediate cause is recorded as Q97825262^[20].
• Q98411271's has immediate cause is recorded as Q97826286^[21].
• Q98411271's has immediate cause is recorded as Q97826992^[22].
• Q98411271's has immediate cause is recorded as Q97827425^[23].
• Q98411271's has immediate cause is recorded as Q97828472^[24].
• Q98411271's has immediate cause is recorded as Q97828525^[25].
• Q98411271's has immediate cause is recorded as Q97828728^[26].

Body

Definition and Type

Q98411271's instance of is recorded as report^[2].